A systematic literature review on the pharmacological applications of the carotenoid norbixin
Palavras-chave:
Carotenoids, Antioxidant properties, Norbixin, Pharmacological activityResumo
Carotenoids play essential roles in human health and can fight and prevent diseases. One carotenoid that is currently attracting scientific interest, particularly for its antioxidant properties, is norbixin. Studies related to its use in the treatment of diseases have become increasingly present in the medical field. This systematic literature review aimed to investigate and gather studies on the pharmacological activity of norbixin for health benefits and the treatment of diseases. Four databases were consulted: Web of Science, PubMed, Scopus, and ScienceDirect. Articles were extracted using a combination of keywords such as 'norbixin', 'antioxidant', 'diseases', 'in vitro', 'in vivo', etc. A total of 173 articles were identified. After applying the inclusion and exclusion criteria, 21 were selected for inclusion in this review. Studies have shown that norbixin, alone or in combination with other treatments, may be effective in DNA protection, tissue engineering, bone repair, and the prevention and treatment of age-related macular degeneration and cardiovascular disease. These results provide a solid basis for further studies aimed at exploring the pharmacological properties of norbixin and enabling its use in therapeutic applications.
Downloads
Referências
ALVES, A.M.M., et al. Evaluation of bone repair after application of a norbixin membrane scaffold with and without laser photobiomodulation (λ 780 nm). Lasers Med Sci., v. 33, n. 7, p. 1493-1504, sep. 2018.
BARCELOS, G. R. M. et al. Bixin and norbixin protect against DNA-damage and alterations of redox status induced by methylmercury exposure in vivo. Environmental and Molecular Mutagenesis, v. 53, n. 7, p. 535–541, 30 jul. 2012.
BENI, A. A. et al. Dietary supplementation with annatto food-coloring extracts increases the resistance of human erythrocytes to hemolysis. Nutrition Research (New York, N.Y.), v. 76, p. 71–81, 1 apr. 2020.
COHEN, J. Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit. Psychological Bulletin, v. 70, n. 4, p. 213–220, 1968.
FONTAINE, V. et al. Anti-Inflammatory Effects and Photo- and Neuro-Protective Properties of BIO203, a New Amide Conjugate of Norbixin, in Development for the Treatment of Age-Related Macular Degeneration (AMD). International Journal of Molecular Sciences, v. 24, n. 6, p. 5296, 10 mar. 2023.
FONTAINE, V. et al. A2E-induced inflammation and angiogenesis in RPE cells in vitro are modulated by PPAR-α, -β/δ, -γ, and RXR antagonists and by norbixin. Aging, v. 13, n. 18, p. 22040–22058, 20 sep. 2021.
FONTAINE, V. et al. Norbixin Protects Retinal Pigmented Epithelium Cells and Photoreceptors against A2E-Mediated Phototoxicity In Vitro and In Vivo. PLOS ONE, v. 11, n. 12, p. e0167793, 16 dec. 2016.
FONTAINE, V. et al. Systemic administration of the di-apocarotenoid norbixin (BIO201) is neuroprotective, preserves photoreceptor function and inhibits A2E and lipofuscin accumulation in animal models of age-related macular degeneration and Stargardt disease. Aging, v. 12, n. 7, p. 6151–6171, 7 apr. 2020.
FONTAINE, V. et al. RAR Inhibitors Display Photo-Protective and Anti-Inflammatory Effects in A2E Stimulated RPE Cells In Vitro through Non-Specific Modulation of PPAR or RXR Transactivation. International journal of molecular sciences, v. 25, n. 5, p. 3037–3037, 6 mar. 2024.
FRANKLIN, V. A. et al. Aqueous extract from urucum (Bixa orellana L.): antimicrobial, antioxidant, and healing activity. Porto Biomed J, v. 8, n. 1, p. e183–e183, 1 jan. 2023.
GARCIA, C. E. R. et al. Bixin and norbixin carotenoids from annatto (Bixa Orellana L.) as antioxidants in meat products. Ciência Rural, v. 42, n. 8, p. 1510–1517, aug. 2012.
GOTO, T. et al. Various Terpenoids Derived from Herbal and Dietary Plants Function as PPAR Modulators and Regulate Carbohydrate and Lipid Metabolism. PPAR Research, v. 2010, p. e483958, 3 jun. 2010.
JEBARI-BENSLAIMAN, S. et al. Pathophysiology of Atherosclerosis. International Journal of Molecular Sciences, v. 23, n. 6, p. 3346, 20 mar. 2022.
JÚNIOR, A.C. et al. Antigenotoxic and antimutagenic potential of annatto pigment (norbixin) against oxidative stress. Genetics and Molecular Research , v. 4, n. 1, p. 94-99, 31 mar. 2005.
KITCHENHAM, B., CHARTERS, S. Guidelines for performing systematic literature reviews in software engineering. Version 2.3. EBSE Technical Report EBSE-2007-01, Keele University and University of Durham, 2007.
KOVARY, K. et al. Biochemical behaviour of norbixin during in vitro DNA damage induced by reactive oxygen species. The British Journal of Nutrition, v. 85, n. 4, p. 431–440, 1 apr. 2001.
LIMA, P.R. et al. Bixin, norbixin and quercetin and their effects on lipid metabolism in rabbits. Brazilian Journal of Veterinary Research and Animal Science, v. 38, n. 4, p. 196–200, 1 jan. 2001.
MOHER, D. et al. Preferred reporting items for systematic review and meta-analyses protocols (PRISMA-P) 2015 statement. Syst Rev, v. 4, n.1, p. 1-9, 1 jan. 2015.
NASCIMENTO, L.D.S. et al. Effect of low intensity photobiomodulation associated with norbixin-based poly (hydroxybutyrate) membrane on post-tenotomy tendon repair. In vivo study. Acta Cirúrgica Brasileira, v. 35, n. 3, 1 jan. 2020.
NASCIMENTO, L.D.S. et al. Effect of norbixin-based poly(hydroxybutyrate) membranes on the tendon repair process after tenotomy in rats. Acta Cirúrgica Brasileira, v. 34, n. 11, 1 nov. 2019.
NHMRC. Guidelines for Guidelines - Assessing risk of bias. 2019. Available in: https://nhmrc.gov.au/guidelinesforguidelines/develop/assessing-risk-bias. Accessed on March 15, 2024.
OUYANG, D. et al. A synergistic effect of Cu2+ and norbixin on DNA damage. Food and Chemical Toxicology, v. 46, n. 8, p. 2802–2807, aug. 2008.
PAGE, M. J. et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. British Medical Journal, v. 372, n. 71, 29 mar. 2021.
PARSIFAL, 2024. Available in: https://parsif.al/. Accessed on March 30, 2024.
PILAI, S., SONI, S., DHULAP, S. Pharmacological and cosmeceutical applications of Bixa Orellana L.: A review of the scientific and patent literature. Indian Journal of Natural Products and Resources (IJNPR), v. 9, n. 4, p. 281–289, 2024.
ROEHRS, M. et al. Annatto carotenoids attenuate oxidative stress and inflammatory response after high-calorie meal in healthy subjects. Food Research International, v. 100, p. 771–779, oct. 2017.
ROEHRS, M. et al. Bixin and Norbixin Have Opposite Effects on Glycemia, Lipidemia, and Oxidative Stress in Streptozotocin-Induced Diabetic Rats. International journal of endocrinology, v. 2014, p. 1–10, 1 jan. 2014.
ROHINI, A. et al. Norbixin, an apocarotenoid derivative activates PPARγ in cardiometabolic syndrome: Validation by in silico and in vivo experimental assessment. Life Sciences, v. 209, p. 69–77, sep. 2018.
ROVANI, B.T. et al. Prooxidant activity of norbixin in model of acute gastric ulcer induced by ethanol in rats. Human & experimental toxicology, v. 35, n. 7, p. 737–746, 9 sep. 2015.
SAINI, R. K. et al. Carotenoids: dietary sources, extraction, encapsulation, bioavailability, and health benefits - A review of recent advancements. Antioxidants, v. 11, n. 4, p. 795, 18 apr. 2022.
SANTOS, A.A.A. et al. Influence of norbixin on plasma cholesterol-associated lipoproteins, plasma arylesterase/paraoxonase activity and hepatic lipid peroxidation of Swiss mice on a high fat diet. Food chemistry, v. 77, n. 4, p. 393–399, 1 jun. 2002.
SATYANARAYANA, A., PRABHAKARA RAO, P.G., RAO, D. G. Chemistry, processing and toxicology of annatto (Bixa orellana L.). Journal of Food Science Technology, v. 40, n. 2, p. 131-141, 2003.
SOMACAL, S. et al. Norbixin, a natural dye that improves serum lipid profile in rabbits and prevents LDL oxidation. Food research international, v. 159, p. 111522–111522, 1 sep. 2022.
SOUSA, R. C. et al. Characterization and assessment of the genotoxicity and biocompatibility of poly (hydroxybutyrate) and norbixin membranes. Acta Cirúrgica Brasileira, v. 35, n. 7, e202000706, 2020.
SOUSA, R. C. et al. In vivo evaluation of bone repair guided with biological membrane based on polyhydroxybutyrate and norbixin. Journal of biomedical materials research. Part B, Applied biomaterials, v. 110, n. 4, p. 743–754, 10 oct. 2021.
TRAN, L. et al. Quality assessment tools used in systematic reviews of in vitro studies: A systematic review. BMC Medical Research Methodology, v. 21, n. 1, 8 may. 2021.
TROMBINO, S. et al. Polymeric Based Hydrogel Membranes for Biomedical Applications. Membranes, v. 13, n. 6, p. 576, 1 jun. 2023.
VIERA, A. J.; GARRETT, J. M. Understanding interobserver agreement: the kappa statistic. Family Medicine, v. 37, n. 5, p. 360–363, 1 may. 2005.
WANG, L. et al. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. Biochemical Pharmacology, v. 92, n. 1, p. 73–89, 2014.
WOHLIN, C. Guidelines for snowballing in systematic literature studies and a replication in software engineering. Proceedings of the 18th International Conference on Evaluation and Assessment in Software Engineering - EASE ’14, n. 38, 2014.
WOŹNIAK-BUDYCH, M. J. Polymeric membranes for biomedical applications. Physical Sciences Reviews, v. 0, n. 0, 16 jun. 2021.
